WASHINGTON, Sept 11 (Reuters) - Taro Pharmaceutical
Industries Ltd. and two of its senior officers received
grand jury subpoenas last week in connection with a federal
antitrust investigation into generic drug pricing, the company
disclosed late on Friday.
Read more
No comments:
Post a Comment